Stacy Lane
Infectious Disease · Pittsburgh, PANPI 1568681336
Payments from drug & device makers
Across 254 payments — averaging $77.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$16K
- Gilead$1K
- AbbVie$703
- Merck$305
- Indivior Inc.$262
- Johnson & Johnson$152
- plus $566 from 15 others
What the payments were for
- Food & beverage$5,66099%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 126 | $16,363 |
| Gilead | 49 | $1,406 |
| AbbVie | 22 | $703 |
| Merck | 17 | $305 |
| Indivior Inc. | 9 | $262 |
| Johnson & Johnson(2 entities) | 6 | $152 |
| Antares Pharma, Inc. | 1 | $122 |
| Theratechnologies Inc. | 4 | $108 |
| EMD Serono, Inc. | 6 | $90 |
| Hologic Sales And Service, LLC | 2 | $38 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Paratek Pharmaceuticals, Inc. | 2 | $26 |
| Alkermes, Inc. | 1 | $24 |
| Mayne Pharma Commercial LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Mylan Institutional Inc. | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Vyera Pharmaceuticals, LLC | 1 | $13 |
| Metuchen Pharmaceuticals | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,756 in reported general payments places this provider in the 85th percentile of 457 infectious disease providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,457 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Pittsburgh
- Ghady HaidarPittsburgh$3.7M
- Sharon RiddlerPittsburgh$1.6M
- Chiu Bin HsiaoPittsburgh$1.6M
- Fernanda SilveiraPittsburgh$1.4M
- Minh-Hong NguyenPittsburgh$1.4M
- Amesh AdaljaPittsburgh$415K
- Micah JacobsPittsburgh$237K
- Booth WainscoatPittsburgh$139K
- Brandon SmithPittsburgh$108K
- Yohei DoiPittsburgh$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.